Cognitive Impairment
Pipeline by Development Stage
Competitive Landscape
13 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
Clinical Trials (15)
Total enrollment: 873 patients across 15 trials
RIVastigmine In Vascular cognitivE Impairment
The Efficacy, Safety, And Tolerability Of Donepezil HCl (E2020) In Patients With CADASIL Who Have Cognitive Impairment
Pharmacokinetics Centella Asiatica Product (CAP) in Mild Cognitive Impairment
A Pharmacodynamics, Safety, and Pharmacokinetics Study of THN201 Versus Donepezil in Healthy Male Volunteers
Ascending Dose Study of CT1812 in Healthy Volunteers
Cognitive Impairment in Treated Breast Cancer Survivors: Possible Approaches
Impact of Resistance Training Volume on Cognitive Function and Physical Performance in Cognitively Impaired Individuals
Digitally Supported Lifestyle Programme to Promote Brain Health Among Older Adults
The Philippine Neurological Association One Database -Dementia
Dual-task Cycling System on Cognitive Function for the Elderly
The Kidney and The Brain Study - Assessment of Cognitive Impairment in Advanced CKD
Effects of Ovarian Hormone Suppression on Vascular and Cognitive Function
Gene Expression, Meditative Movement, and Emotional Distress (GME)
Mental Activity During (TMS) Therapy for Depression
Vascular Mechanisms for the Effects of Loss of Ovarian Hormone Function on Cognition in Women
Phase Legend
Key Insights
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.